Literature DB >> 10618523

Amino terminal peptides of the ring infected erythrocyte surface antigen of Plasmodium falciparum bind specifically to erythrocytes.

R Vera Bravo1, V Marín, J García, M Urquiza, E Torres, M Trujillo, J Rosas, M E Patarroyo.   

Abstract

The Ring-Infected Erythrocyte Surface Antigen (Pf155/RESA) sequence was chemically synthesized in fifty four 20-mer sequential peptides, covering the entire protein, each of which was tested in erythrocyte binding assays. Peptides 6671 and 6673, corresponding to residues 141-160 and 181-200, respectively, presented a high specific binding activity to erythrocytes with affinity constants of 190 nM and 105 nM respectively. Their binding was sensitive to previous enzymatic treatment of erythrocytes. A region of peptide 6673 has been identified, very recently, as a B-cell epitope, target of neutralizing antibodies (Siddique AB, Iqbal J, Ahlborg N, Wâhlin FB, Perlmann P, Berzins K. Antibodies to nonrepeat sequences of antigen Pf155/RESA of Plasmodium falciparum inhibit parasite growth in vitro. Parasitol Res 1998;84:485-91). The critical residues for erythrocyte binding for peptide 6671 (MTDVNRYRYSNNYEAIPHIS) and for peptide 6673 (LGRSGGDIIKKMQTLWDEIM) were recognized. Based on these data, the presence of five functional regions of RESA is postulated.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10618523     DOI: 10.1016/s0264-410x(99)00405-3

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  4 in total

1.  Identifying Plasmodium falciparum merozoite surface antigen 3 (MSP3) protein peptides that bind specifically to erythrocytes and inhibit merozoite invasion.

Authors:  Luis E Rodríguez; Hernando Curtidor; Marisol Ocampo; Javier Garcia; Alvaro Puentes; John Valbuena; Ricardo Vera; Ramses López; Manuel E Patarroyo
Journal:  Protein Sci       Date:  2005-07       Impact factor: 6.725

2.  Liver stage antigen 3 Plasmodium falciparum peptides specifically interacting with HepG2 cells.

Authors:  Javier E García; Hernando Curtidor; Ramses López; Luis Rodríguez; Ricardo Vera; John Valbuena; Jaiver Rosas; Marisol Ocampo; Alvaro Puentes; Martha Forero; Manuel A Patarroyo; Manuel Elkin Patarroyo
Journal:  J Mol Med (Berl)       Date:  2004-08-07       Impact factor: 4.599

Review 3.  Strategies for developing multi-epitope, subunit-based, chemically synthesized anti-malarial vaccines.

Authors:  M E Patarroyo; G Cifuentes; A Bermúdez; M A Patarroyo
Journal:  J Cell Mol Med       Date:  2008-10       Impact factor: 5.310

4.  A Large Size Chimeric Highly Immunogenic Peptide Presents Multistage Plasmodium Antigens as a Vaccine Candidate System against Malaria.

Authors:  José Manuel Lozano; Yahson Varela; Yolanda Silva; Karen Ardila; Martha Forero; Laura Guasca; Yuly Guerrero; Adriana Bermudez; Patricia Alba; Magnolia Vanegas; Manuel Elkin Patarroyo
Journal:  Molecules       Date:  2017-11-01       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.